A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies.
Mitochondrial encephalomyopathies are usually divided into three distinct clinical subgroups: (1) mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS); (2) myoclonus epilepsy associated with ragged-red fibres (MERRF); and (3) chronic progressive external ophthalmoplegia (CPEO) including Kearns-Sayre syndrome. Large deletions of human mitochondrial DNA and a transition mutation at the mitochondrial transfer RNALys gene give rise to CPEO including Kearns-Sayre syndrome and MERRF, respectively. Here we report an A-to-G transition mutation at nucleotide pair 3,243 in the dihydrouridine loop of mitochondrial tRNA(Leu)(UUR) that is specific to patients with MELAS. Because this mutation creates an ApaI restriction site, we could perform a simple molecular diagnostic test for the disease. The mutation was present in 26 out of 31 independent MELAS patients and 1 out of 29 CPEO patients, but absent in the 5 MERRF and 50 controls tested. Southern blot analysis confirmed that the mutant DNA always coexists with the wild-type DNA (heteroplasmy).
Goto
Y
Y
Division of Ultrastructural Research, National Center of Neurology and Psychiatry, Tokyo, Japan.
Nonaka
I
I
Horai
S
S
D001483:Base Sequence; D001927:Brain Diseases / Q000145:classification / Q000175:diagnosis / Q000235:genetics*; D006801:Humans; D008297:Male; D008931:Mitochondria, Muscle / Q000378:metabolism; D008969:Molecular Sequence Data; D009154:Mutation; D012356:RNA, Transfer, Leu / Q000235:genetics*; D012016:Reference Values; D015183:Restriction Mapping; D012689:Sequence Homology, Nucleic Acid
D012356:RNA, Transfer, Leu